$JCTC
JEWETT CAMERON TRADING CO LTD Stock $jctc

$jctc Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000155335023000265 Filed on April 13, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue	$18.95M	$8.143M	$14.06M
YoY Change	-9.45%	-42.08%	34.42%
Cost Of Revenue	$14.53M	$6.223M	$10.64M
YoY Change	-6.66%	-41.5%	35.5%
Gross Profit	$4.413M	$1.921M	$3.424M
YoY Change	-17.55%	-43.91%	31.2%
Gross Profit Margin	23.29%	23.58%	24.35%
Selling, General & Admin	$3.062M	$1.096M	$2.643M
YoY Change	172.05%	-58.54%	0.89%
% of Gross Profit	69.39%	57.07%	77.2%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$99.96K	$88.08K	$84.07K
YoY Change	20.01%	4.77%	40.12%
% of Gross Profit	2.26%	4.59%	2.46%
Operating Expenses	$3.162M	$3.131M	$2.727M
YoY Change	-5.12%	14.78%	2.15%
Operating Profit	$1.251M	-$1.210M	$696.7K
YoY Change	-38.06%	-273.68%	-1261.23%
Interest Expense	-$152.9K	$114.5K	-$30.62K
YoY Change	-418.75%	-474.04%
% of Operating Profit	-12.22%		-4.39%
Other Income/Expense, Net	$0.00	-$114.5K	-$298.0K
YoY Change	-100.0%	-61.57%
Pretax Income	$1.098M	-$1.325M	$368.1K
YoY Change	-44.33%	-459.83%	-713.53%
Income Tax	$363.2K	-$352.6K	$98.30K
% Of Pretax Income	33.07%		26.7%
Net Earnings	$735.0K	-$972.0K	$269.8K
YoY Change	-50.81%	-460.25%	-639.64%
Net Earnings / Revenue	3.88%	-11.94%	1.92%
Basic Earnings Per Share	$0.21	-$0.28	$0.08
Diluted Earnings Per Share	$0.21	-$0.28	$77.25K
COMMON SHARES
Basic Shares Outstanding	3.499M shares	3.499M shares	3.493M shares
Diluted Shares Outstanding	3.499M shares	3.499M shares	3.493M shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.716M	$268.4K	$899.1K
YoY Change	27.49%	-70.15%	-68.89%
Cash & Equivalents	$2.716M	$268.4K	$899.1K
Short-Term Investments
Other Short-Term Assets	$870.2K	$1.003M	$2.818M
YoY Change	-61.52%	-64.42%	55.7%
Inventory	$20.53M	$23.08M	$18.63M
Prepaid Expenses	$870.1K	$794.6K
Receivables	$7.530M	$4.261M	$9.137M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$31.65M	$28.61M	$31.48M
YoY Change	-2.82%	-9.12%	58.85%
LONG-TERM ASSETS
Property, Plant & Equipment	$4.746M	$4.931M	$4.638M
YoY Change	1.81%	6.31%	35.97%
Goodwill
YoY Change
Intangibles	$134.4K	$32.82K
YoY Change	346.63%
Long-Term Investments
YoY Change
Other Assets	$391.6K	$398.0K
YoY Change
Total Long-Term Assets	$5.272M	$5.362M	$4.672M
YoY Change	12.37%	14.76%	37.01%
TOTAL ASSETS
Total Short-Term Assets	$31.65M	$28.61M	$31.48M
Total Long-Term Assets	$5.272M	$5.362M	$4.672M
Total Assets	$36.92M	$33.97M	$36.16M
YoY Change	-0.9%	-6.04%	55.65%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.631M	$710.2K	$1.661M
YoY Change	46.6%	-57.24%	118.51%
Accrued Expenses	$2.332M	$1.692M	$2.078M
YoY Change	14.03%	-18.62%	7.69%
Deferred Revenue
YoY Change
Short-Term Debt	$8.000M	$8.500M	$9.500M
YoY Change	-11.11%	-10.53%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$13.11M	$10.90M	$13.24M
YoY Change	2.11%	-17.66%	311.15%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change			-100.0%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change			-100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$13.11M	$10.90M	$13.24M
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$13.11M	$10.90M	$13.36M
YoY Change	1.09%	-18.43%	295.41%
SHAREHOLDERS EQUITY
Retained Earnings	$22.22M	$21.48M
YoY Change	-2.28%
Common Stock	$825.5K	$825.5K
YoY Change	0.17%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$23.81M	$23.07M	$22.79M
YoY Change
Total Liabilities & Shareholders Equity	$36.92M	$33.97M	$36.16M
YoY Change	-0.9%	-6.04%	55.65%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	$735.0K	-$972.0K	$269.8K
YoY Change	-50.81%	-460.25%	-639.64%
Depreciation, Depletion And Amortization	$99.96K	$88.08K	$84.07K
YoY Change	20.01%	4.77%	40.12%
Cash From Operating Activities	$2.964M	-$2.109M	-$4.518M
YoY Change	61.59%	-53.33%	73.12%
INVESTING ACTIVITIES
Capital Expenditures	-$85.99K	$265.5K	-$318.0K
YoY Change	-16.48%	-183.47%	-6.46%
Acquisitions
YoY Change
Other Investing Activities	-$102.5K
YoY Change
Cash From Investing Activities	-$16.51K	-$265.5K	-$318.0K
YoY Change	-83.96%	-16.53%	-6.46%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-500.0K	900.0K	4.500M
YoY Change	0.0%	-80.0%
NET CHANGE
Cash From Operating Activities	2.964M	-2.109M	-4.518M
Cash From Investing Activities	-16.51K	-265.5K	-318.0K
Cash From Financing Activities	-500.0K	900.0K	4.500M
Net Change In Cash	2.448M	-1.474M	-336.4K
YoY Change	98.77%	338.21%	-88.6%
FREE CASH FLOW
Cash From Operating Activities	$2.964M	-$2.109M	-$4.518M
Capital Expenditures	-$85.99K	$265.5K	-$318.0K
Free Cash Flow	$3.050M	-$2.374M	-$4.200M
YoY Change	57.44%	-43.48%	85.04%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Incremental Common Shares Attributable To Written Put Options IncrementalCommonSharesAttributableToWrittenPutOptions		shares
CY2022Q1	us-gaap	Incremental Common Shares Attributable To Written Put Options IncrementalCommonSharesAttributableToWrittenPutOptions		shares
	dei	Entity Central Index Key EntityCentralIndexKey	0000885307
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--08-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
CY2023Q1	us-gaap	Other Income OtherIncome		usd
	us-gaap	Other Income OtherIncome		usd
CY2023Q1	jctcf	Accrual For Legal Claim AccrualForLegalClaim		usd
	jctcf	Accrual For Legal Claim AccrualForLegalClaim		usd
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Written Put Options IncrementalCommonSharesAttributableToWrittenPutOptions		shares
	us-gaap	Incremental Common Shares Attributable To Written Put Options IncrementalCommonSharesAttributableToWrittenPutOptions		shares
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-02-28
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-19954
	dei	Entity Registrant Name EntityRegistrantName	JEWETT-CAMERON TRADING COMPANY LTD
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	A1
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	00-0000000
	dei	Entity Address Address Line1 EntityAddressAddressLine1	32275 N.W. Hillcrest
	dei	Entity Address City Or Town EntityAddressCityOrTown	North Plains
	dei	Entity Address State Or Province EntityAddressStateOrProvince	OR
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	97133
	dei	City Area Code CityAreaCode	(503)
	dei	Local Phone Number LocalPhoneNumber	647-0110
	dei	Security12b Title Security12bTitle	Common Stock, no par value
	dei	Trading Symbol TradingSymbol	JCTCF
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	3498899	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	268389	usd
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	484463	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2022Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4261256	usd
CY2022Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	7191646	usd
CY2023Q1	us-gaap	Inventory Net Of Allowances Customer Advances And Progress Billings InventoryNetOfAllowancesCustomerAdvancesAndProgressBillings	449707	usd
CY2022Q3	us-gaap	Inventory Net Of Allowances Customer Advances And Progress Billings InventoryNetOfAllowancesCustomerAdvancesAndProgressBillings	800000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	23079647	usd
CY2022Q3	us-gaap	Inventory Net InventoryNet	20632313	usd
CY2023Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	794566	usd
CY2022Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1112575	usd
CY2023Q1	us-gaap	Prepaid Taxes PrepaidTaxes	208138	usd
CY2022Q3	us-gaap	Prepaid Taxes PrepaidTaxes	208963	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	28611996	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	29629960	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4931022	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4828420	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	32822	usd
CY2022Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	33358	usd
CY2023Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	397990	usd
CY2022Q3	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	24998	usd
CY2023Q1	us-gaap	Assets Assets	33973830	usd
CY2022Q3	us-gaap	Assets Assets	34516736	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	710174	usd
CY2022Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	1566047	usd
CY2023Q1	us-gaap	Notes Payable NotesPayable	8500000	usd
CY2022Q3	us-gaap	Notes Payable NotesPayable	7000000	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1691501	usd
CY2022Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1856039	usd
CY2023Q1	us-gaap	Liabilities Liabilities	10901675	usd
CY2022Q3	us-gaap	Liabilities Liabilities	10422086	usd
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	21567564	shares
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	21567564	shares
CY2023Q1	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2022Q3	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q1	us-gaap	Preferred Stock No Par Value PreferredStockNoParValue	0
CY2022Q3	us-gaap	Preferred Stock No Par Value PreferredStockNoParValue	0
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3498899	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3495342	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	825468	usd
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	824629	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	765055	usd
CY2022Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	742591	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	21481632	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	22527430	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	23072155	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	24094650	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	33973830	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	34516736	usd
CY2023Q1	us-gaap	Revenues Revenues	8143421	usd
CY2022Q1	us-gaap	Revenues Revenues	14060751	usd
	us-gaap	Revenues Revenues	20720921	usd
	us-gaap	Revenues Revenues	26978475	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	6222879	usd
CY2022Q1	us-gaap	Cost Of Revenue CostOfRevenue	10636524	usd
	us-gaap	Cost Of Revenue CostOfRevenue	15940679	usd
	us-gaap	Cost Of Revenue CostOfRevenue	21089386	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1045798	usd
	us-gaap	Net Income Loss NetIncomeLoss	-121322	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.28
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.08
CY2023Q1	us-gaap	Gross Profit GrossProfit	1920542	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	3424227	usd
	us-gaap	Gross Profit GrossProfit	4780242	usd
	us-gaap	Gross Profit GrossProfit	5889089	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1096090	usd
CY2022Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	684116	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1922897	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1672403	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	88079	usd
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	84071	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	199615	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	153709	usd
CY2023Q1	us-gaap	Salaries And Wages SalariesAndWages	1946458	usd
CY2022Q1	us-gaap	Salaries And Wages SalariesAndWages	1959300	usd
	us-gaap	Salaries And Wages SalariesAndWages	3874613	usd
	us-gaap	Salaries And Wages SalariesAndWages	3833418	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	3130627	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	2727487	usd
	us-gaap	Operating Expenses OperatingExpenses	5997125	usd
	us-gaap	Operating Expenses OperatingExpenses	5659530	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-1210085	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	696740	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1216883	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	229559	usd
CY2022Q1	us-gaap	Other Income OtherIncome	2000	usd
	us-gaap	Other Income OtherIncome	5000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	114530	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	30620	usd
	us-gaap	Interest Expense InterestExpense	201082	usd
	us-gaap	Interest Expense InterestExpense	50896	usd
CY2022Q1	jctcf	Accrual For Legal Claim AccrualForLegalClaim	300000	usd
	jctcf	Accrual For Legal Claim AccrualForLegalClaim	300000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-114530	usd
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-328620	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-201082	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-345896	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-1324615	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	368120	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-1417965	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-116337	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-352577	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	98300	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-372167	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4985	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-972038	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	269820	usd
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.30
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.28
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.08
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.30
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3498899	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3492842	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3497543	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3491969	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3498899	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3492842	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3497543	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3491969	shares
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	22873689	usd
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	39386	usd
	us-gaap	Profit Loss ProfitLoss	-121322	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	22791753	usd
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	17452	usd
	us-gaap	Profit Loss ProfitLoss	1285445	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	24094650	usd
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	23303	usd
	us-gaap	Profit Loss ProfitLoss	-1045798	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	23072155	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1045798	usd
	us-gaap	Net Income Loss NetIncomeLoss	-121322	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	199615	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	153709	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	-23303	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	-39386	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-372992	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	8889	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2930390	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2050751	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2447334	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	4238783	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-318009	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	254073	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-1020411	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	591335	usd
	us-gaap	Increase Decrease In Prepaid Taxes IncreaseDecreaseInPrepaidTaxes	-825	usd
	us-gaap	Increase Decrease In Prepaid Taxes IncreaseDecreaseInPrepaidTaxes	5247	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1414393	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5876857	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	301681	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	908401	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-301681	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-908401	usd
	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt	1500000	usd
	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt	6500000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1500000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	6500000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-216074	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-285258	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	484463	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1184313	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	268389	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	899055	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_846_eus-gaap--UseOfEstimates_zMMLOEKFM52H" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><b><span id="xdx_867_zRQqaZdZMoWS">Estimates</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3pc; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">The preparation of consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates incorporated into the Company’s consolidated financial statements include the estimated useful lives for depreciable and amortizable assets, the estimated allowances for doubtful accounts receivable and inventory obsolescence, possible product liability and possible product returns, and litigation contingencies and claims. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	268389	usd
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	484463	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-972038	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	269820	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1045798	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-121322	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3498899	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3492842	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3497543	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3491969	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3498899	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3492842	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3497543	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3491969	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	268389	usd
CY2023Q1	jctcf	Wood Products And Metal Products WoodProductsAndMetalProducts	22355455	usd
CY2022Q3	jctcf	Wood Products And Metal Products WoodProductsAndMetalProducts	20130063	usd
CY2023Q1	jctcf	Agricultural Seed Products AgriculturalSeedProducts	724192	usd
CY2022Q3	jctcf	Agricultural Seed Products AgriculturalSeedProducts	502250	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	23079647	usd
CY2022Q3	us-gaap	Inventory Net InventoryNet	20632313	usd
CY2023Q1	jctcf	Office Equipment OfficeEquipment	648978	usd
CY2022Q3	jctcf	Office Equipment OfficeEquipment	636501	usd
CY2023Q1	jctcf	Warehouse Equipment WarehouseEquipment	1714239	usd
CY2022Q3	jctcf	Warehouse Equipment WarehouseEquipment	1504867	usd
CY2023Q1	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	6172975	usd
CY2022Q3	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	6168080	usd
CY2023Q1	us-gaap	Land Land	559065	usd
CY2022Q3	us-gaap	Land Land	559065	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	9095257	usd
CY2022Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	8868513	usd
CY2023Q1	jctcf	Accumulated Depreciation Property Plant And Equipment AccumulatedDepreciationPropertyPlantAndEquipment	-4164235	usd
CY2022Q3	jctcf	Accumulated Depreciation Property Plant And Equipment AccumulatedDepreciationPropertyPlantAndEquipment	-4040093	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4931022	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4828420	usd
CY2023Q1	us-gaap	Intangible Assets Current IntangibleAssetsCurrent	50695	usd
CY2022Q3	us-gaap	Intangible Assets Current IntangibleAssetsCurrent	50695	usd
CY2023Q1	us-gaap	Accumulated Amortization Deferred Finance Costs AccumulatedAmortizationDeferredFinanceCosts	17873	usd
CY2022Q3	us-gaap	Accumulated Amortization Deferred Finance Costs AccumulatedAmortizationDeferredFinanceCosts	17337	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	32822	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	33358	usd
CY2023Q1	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	397990	usd
CY2022Q3	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	24998	usd
CY2023Q1	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	10000000	usd
	us-gaap	Line Of Credit Facility Maximum Monthend Outstanding Amount LineOfCreditFacilityMaximumMonthendOutstandingAmount	8500000	usd
CY2022Q3	us-gaap	Line Of Credit Facility Maximum Monthend Outstanding Amount LineOfCreditFacilityMaximumMonthendOutstandingAmount	7000000	usd
CY2023Q1	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.0612	pure
CY2023Q1	jctcf	Available To Be Issued AvailableToBeIssued	17074	shares
	us-gaap	Pension Contributions PensionContributions	276780	usd
	us-gaap	Pension Contributions PensionContributions	288216	usd
	us-gaap	Revenues Revenues	20720921	usd
	us-gaap	Revenues Revenues	26978475	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-1417965	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-116337	usd
CY2023Q1	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Other Noncurrent Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets	33973830	usd
CY2022Q1	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Other Noncurrent Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets	36156687	usd
	us-gaap	Capital Expenditure Discontinued Operations CapitalExpenditureDiscontinuedOperations	301681	usd
	us-gaap	Capital Expenditure Discontinued Operations CapitalExpenditureDiscontinuedOperations	908401	usd
	jctcf	Sales To Customers In Excess Of10 Of Total Sales SalesToCustomersInExcessOf10OfTotalSales	12630634	usd
	jctcf	Sales To Customers In Excess Of10 Of Total Sales SalesToCustomersInExcessOf10OfTotalSales	13029830	usd
	jctcf	United States Sales UnitedStatesSales	19929828	usd
	jctcf	United States Sales UnitedStatesSales	25657040	usd
	jctcf	Canada Sales CanadaSales	354185	usd
	jctcf	Canada Sales CanadaSales	426425	usd
	jctcf	Europe Sales EuropeSales	40525	usd
	jctcf	Europe Sales EuropeSales	24913	usd
	jctcf	Mexico Latin America Sales MexicoLatinAmericaSales	301615	usd
	jctcf	Mexico Latin America Sales MexicoLatinAmericaSales	632334	usd
	jctcf	Asia Pacific Sales AsiaPacificSales	94768	usd
	jctcf	Asia Pacific Sales AsiaPacificSales	237763	usd
	us-gaap	Concentration Risk Customer ConcentrationRiskCustomer	67%
	us-gaap	Concentration Risk Customer ConcentrationRiskCustomer	69%
	jctcf	Concentration Volume Of Purchases ConcentrationVolumeOfPurchases	9895011	usd
	jctcf	Concentration Volume Of Purchases ConcentrationVolumeOfPurchases	14000039	usd
	us-gaap	Interest Paid Net InterestPaidNet	186906	usd
	us-gaap	Interest Paid Net InterestPaidNet	50896	usd
	jctcf	Final Settlement FinalSettlement	300000	usd
CY2023Q1	us-gaap	Line Of Credit LineOfCredit	500000	usd

Files In Submission

Name	View Source	Status
jctcf-20230228_cal.xml	Edgar Link	unprocessable
0001553350-23-000265-index-headers.html	Edgar Link	pending
0001553350-23-000265-index.html	Edgar Link	pending
0001553350-23-000265.txt	Edgar Link	pending
0001553350-23-000265-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
jctcf-20230228.xsd	Edgar Link	pending
jctcf_10q.htm	Edgar Link	pending
jctcf_ex31z1.htm	Edgar Link	pending
jctcf_ex31z2.htm	Edgar Link	pending
jctcf_ex32z1.htm	Edgar Link	pending
jctcf_ex32z2.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
jctcf-20230228_def.xml	Edgar Link	unprocessable
jctcf-20230228_lab.xml	Edgar Link	unprocessable
jctcf-20230228_pre.xml	Edgar Link	unprocessable
jctcf_10q_htm.xml	Edgar Link	completed
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$JCTC
JEWETT CAMERON TRADING CO LTD Stock $jctc

2023 Q2 Form 10-Q Financial Statement

#000155335023000265 Filed on April 13, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$JCTC JEWETT CAMERON TRADING CO LTD Stock $jctc

2023 Q2 Form 10-Q Financial Statement

#000155335023000265 Filed on April 13, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$JCTC
JEWETT CAMERON TRADING CO LTD Stock $jctc